- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03444363
Periodontal Treatment With Diode Laser in the Patients With Diabetes Melitus
February 22, 2018 updated by: Abubekir Eltas, Çanakkale Onsekiz Mart University
Evaluation of Long-Term Effects of Diode Laser Application on Periodontal Healing, Serum C-Reactive Protein and HbA1c Levels in Periodontal Treatment of Uncontrolled Type-2 Diabetic Subjects With Chronic Periodontitis
This study aimed to investigate the effects of diode laser (DL) in addition to non-surgical periodontal treatment on periodontal parameters, systemic inflammatory response, and serum hemoglobin A1c (HbA1c) level in patients with uncontrolled type 2 diabetes mellitus (T2DM) and chronic periodontitis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study was designed as a randomized, controlled, full-mouth, 6-month clinical trial.
37 patients (20 women and 17 men) with uncontrolled T2DM and chronic periodontitis who were selected from among those admitting to Dentistry Faculty of Inonu University and Turgut Ozal Medical Center completed this study.
The patients were divided into two groups.
The individuals in the control group underwent placebo laser treatment in addition to scaling and root planing (SRP).
The individuals in the study group underwent DL (1 W power) in addition to SRP.
Clinical index measurements were performed before treatment (T0), 3 months after treatment (T1), and 6 months after treatment (T2).
Plaque index (PI), gingival index (GI), bleeding on probing (BOP), clinical attachment level (CAL), and probing depth (PD) were measured to determine periodontal status.
HbA1c and C-reactive protein (CRP) levels were also analyzed using blood samples.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Malatya, Turkey, 44000
- Abubekir Eltas
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Having a diagnosis of type-2 DM according to the ADA criteria for at least two years before the study, HbA1c⩾7%,28
- Having no change in antidiabetic drugs in the last 3 months,
- Having no major diabetes complications (because chronic complications of diabetes complicate metabolic control),
- Presence of generalized CP,29
- Presence of an area with a pocket depth of 4-7 mm in at least four teeth in the upper jaw,
- Presence of at least 20 teeth in the mouth,
- Having no any systemic illness except for DM,
- Having no smoke,
- Receiving no periodontal treatment in the last 12 months,
- Receiving no antibiotics or anti-inflammatory drugs for a long period in the last 6 months,
- Not being pregnant or not to breastfeed,
- Having no third molars.
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Study group
SRP plus diode laser (810 nm wavelength, 1 W power)
|
Laser application in addition to SRP
Other Names:
|
Active Comparator: Control group
SRP plus placebo
|
Placebo laser application in addition to SRP
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Laboratory findings
Time Frame: Six months
|
Serum HbA1c levels were measured using the high-performance liquid chromatography method.
|
Six months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical findings
Time Frame: Six months
|
Probing depth (PD) was measured the distance between the gingival margin and the deepest aspect of the pocket (mm).
|
Six months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Mustafa O Uslu, Dr., Inonu University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 20, 2013
Primary Completion (Actual)
February 15, 2014
Study Completion (Actual)
December 23, 2014
Study Registration Dates
First Submitted
February 15, 2018
First Submitted That Met QC Criteria
February 22, 2018
First Posted (Actual)
February 23, 2018
Study Record Updates
Last Update Posted (Actual)
February 23, 2018
Last Update Submitted That Met QC Criteria
February 22, 2018
Last Verified
February 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2013/104
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
Medical College of WisconsinMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
SanofiCompletedType 1 Diabetes Mellitus-Type 2 Diabetes MellitusHungary, Russian Federation, Germany, Poland, Japan, United States, Finland
-
Medical College of WisconsinMedical University of South Carolina; National Institute of Diabetes and Digestive...Active, not recruitingDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical College of WisconsinNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
Clinical Trials on Laser group
-
First Affiliated Hospital of Fujian Medical UniversityUnknown
-
China Medical University HospitalUnknown
-
University of Nove de JulhoUnknown
-
Charles Cornell, MDUnknownEpidermal Thickening, UnspecifiedUnited States
-
University of Nove de JulhoWithdrawnNasal Fracture
-
Cairo UniversityCompletedBimaxillary ProtrusionEgypt
-
William Beaumont HospitalsActive, not recruitingUrinary Bladder, Overactive | Urinary Incontinence | Urinary Tract Infections | Stress Urinary Incontinence | Dyspareunia | Menopause Related Conditions | Genitourinary System; Disorder, Female | Burning Vagina | Irritation; VaginaUnited States
-
Paul CrawfordRecruiting
-
Centre Hospitalier Universitaire de NiceCompleted